Your browser doesn't support javascript.
loading
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses.
Cañadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook; Kitajima, Shunsuke; Jenkins, Russell William; Christensen, Camilla Laulund; Campisi, Marco; Kuang, Yanan; Zhang, Yanxi; Gjini, Evisa; Zhang, Gao; Tian, Tian; Sen, Debattama Rai; Miao, Diana; Imamura, Yu; Thai, Tran; Piel, Brandon; Terai, Hideki; Aref, Amir Reza; Hagan, Timothy; Koyama, Shohei; Watanabe, Masayuki; Baba, Hideo; Adeni, Anika Elise; Lydon, Christine Anne; Tamayo, Pablo; Wei, Zhi; Herlyn, Meenhard; Barbie, Thanh Uyen; Uppaluri, Ravindra; Sholl, Lynnette Marie; Sicinska, Ewa; Sands, Jacob; Rodig, Scott; Wong, Kwok Kin; Paweletz, Cloud Peter; Watanabe, Hideo; Barbie, David Allen.
Afiliação
  • Cañadas I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Thummalapalli R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kim JW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kitajima S; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Jenkins RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Christensen CL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Campisi M; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Kuang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zhang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gjini E; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Zhang G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tian T; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Sen DR; Melanoma Research Center and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Miao D; Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, USA.
  • Imamura Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Thai T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Piel B; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Terai H; Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Aref AR; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Hagan T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Koyama S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Watanabe M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Baba H; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Adeni AE; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lydon CA; Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tamayo P; Gastroenterological Surgery, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Wei Z; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Herlyn M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Barbie TU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Uppaluri R; Moores Cancer Center and School of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Sholl LM; Department of Computer Science, New Jersey Institute of Technology, Newark, NJ, USA.
  • Sicinska E; Melanoma Research Center and Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA, USA.
  • Sands J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rodig S; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Wong KK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Paweletz CP; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
  • Watanabe H; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Barbie DA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Med ; 24(8): 1143-1150, 2018 08.
Article em En | MEDLINE | ID: mdl-30038220
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Interferons / Retrovirus Endógenos / Imunidade Inata / Neoplasias Limite: Animals / Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Interferons / Retrovirus Endógenos / Imunidade Inata / Neoplasias Limite: Animals / Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos